12 Health Care Stocks Moving In Wednesday's Intraday Session
Portfolio Pulse from Benzinga Insights
During Wednesday's intraday session, several healthcare stocks experienced significant movements. Shattuck Labs (STTK) saw a 93.8% increase, while Reshape Lifesciences (RSLS) rose by 89.48%. C4 Therapeutics (CCCC) and Avalo Therapeutics (AVTX) also saw substantial gains. Conversely, OneMedNet (ONMD) and Processa Pharma (PCSA) were among the stocks that declined, with drops of 21.7% and 19.84%, respectively.

December 13, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Avalo Therapeutics shares increased by 81.84% to $0.06, with a market cap of $12.1 million.
The significant stock price increase could attract more attention and drive short-term trading activity.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
C4 Therapeutics shares surged 86.32% to $4.36, with a market cap of $214.8 million.
The impressive gain in share price reflects strong investor confidence, which may persist in the short term.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Reshape Lifesciences stock jumped 89.48% to $0.48, with a market cap of $6.2 million.
The substantial rise in stock price indicates a positive market reaction that could potentially continue in the short term.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
Shattuck Labs stock soared by 93.8% to $4.09, with a market cap of $173.7 million.
The significant intraday increase in stock price suggests strong investor interest and positive sentiment, which could lead to continued short-term momentum.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
OneMedNet shares fell by 21.7% to $0.8, with a market cap of $25.8 million.
The drop in stock price could indicate negative sentiment or reactions to recent events, likely affecting the stock negatively in the short term.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 100
NEGATIVE IMPACT
Processa Pharma stock declined 19.84% to $0.65, with a market cap of $16.0 million.
The significant decrease in stock price suggests a bearish outlook that may continue to impact the stock in the short term.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100